Targeted expression of BikDD combined with metronomic doxorubicin induces synergistic antitumor effect through Bax activation in hepatocellular carcinoma

Conventional chemotherapy is commonly used to treat advanced non-resectable hepatocellular carcinoma (HCC) but this treatment modality has not demonstrated convincing survival benefit in HCC patients. Our previous studies indicated that targeted expression of therapeutic BikDD driven by a liver canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Huei-Yue, Chen, Hui-Yu, Lai, Wei-Chen, Hung, Mien-Chie, Li, Long-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695153/
https://www.ncbi.nlm.nih.gov/pubmed/26247632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695153/
https://www.ncbi.nlm.nih.gov/pubmed/26247632

Ejemplares similares